View Financial HealthThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsCBTX 배당 및 자사주 매입배당 기준 점검 2/6핵심 정보1.8%배당 수익률0.5%자사주 매입 수익률총 주주 수익률2.3%미래 배당 수익률2.0%배당 성장률24.6%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향35%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Jun 21Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 28 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (4.3%). Lower than average of industry peers (3.2%).Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).Upcoming Dividend • Dec 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 December 2021. Payment date: 14 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.3%).Upcoming Dividend • Sep 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 2.0%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.4%).Upcoming Dividend • Jun 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 June 2021. Payment date: 15 July 2021. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (3.4%). Lower than average of industry peers (2.3%).Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).모든 업데이트 보기Recent updatesRecent Insider Transactions Derivative • Sep 27Senior EVP & CCO exercised options to buy US$192k worth of stock.On the 23rd of September, Joe West exercised options to buy 6k shares at a strike price of around US$11.32, costing a total of US$73k. This transaction amounted to 11% of their direct individual holding at the time of the trade. Since March 2022, Joe's direct individual holding has increased from 49.01k shares to 57.84k. Company insiders have collectively bought US$237k more than they sold, via options and on-market transactions, in the last 12 months.Seeking Alpha • Sep 22CBTX declares $0.13 dividendCBTX (NASDAQ:CBTX) declares $0.13/share quarterly dividend, in line with previous. Forward yield 1.67% Payable Oct. 14; for shareholders of record Sept. 29; ex-div Sept. 28. See CBTX Dividend Scorecard, Yield Chart, & Dividend Growth.Buying Opportunity • Sep 21Now 20% undervaluedOver the last 90 days, the stock is up 15%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.Buying Opportunity • Aug 25Now 20% undervaluedOver the last 90 days, the stock is up 9.5%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.Major Estimate Revision • Aug 04Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$297.8m to US$254.6m. EPS estimate fell from US$1.73 to US$1.54 per share. Net income forecast to grow 200% next year vs 9.8% growth forecast for Banks industry in the US. Consensus price target up from US$32.67 to US$34.67. Share price was steady at US$30.66 over the past week.Reported Earnings • Jul 29Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: US$0.48 (up from US$0.48 in 2Q 2021). Revenue: US$38.3m (down 3.3% from 2Q 2021). Net income: US$11.7m (flat on 2Q 2021). Profit margin: 31% (up from 30% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 147%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.Seeking Alpha • Jul 28CBTX GAAP EPS of $0.48 beats by $0.06, revenue of $38.42M misses by $1.13MCBTX press release (NASDAQ:CBTX): Q2 GAAP EPS of $0.48 beats by $0.06. Revenue of $38.42M (+11.3% Y/Y) misses by $1.13M.Upcoming Dividend • Jun 21Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 28 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (4.3%). Lower than average of industry peers (3.2%).Recent Insider Transactions • Jun 09Independent Director recently bought US$300k worth of stockOn the 3rd of June, Michael Havard bought around 10k shares on-market at roughly US$28.60 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$64k more in shares than they have sold in the last 12 months.Recent Insider Transactions Derivative • Jun 08Senior EVP & CCO exercised options to buy US$253k worth of stock.On the 4th of June, Joe West exercised options to buy 9k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 18% of their direct individual holding at the time of the trade. Since March 2022, Joe has owned 49.01k shares directly. Company insiders have collectively sold US$135k more than they bought, via options and on-market transactions in the last 12 months.Recent Insider Transactions • May 07Insider recently sold US$235k worth of stockOn the 5th of May, Deborah Dinsmore sold around 8k shares on-market at roughly US$28.70 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Major Estimate Revision • May 05Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$276.8m to US$285.2m. EPS estimate increased from US$1.47 to US$1.65 per share. Net income forecast to grow 135% next year vs 2.6% growth forecast for Banks industry in the US. Consensus price target of US$33.67 unchanged from last update. Share price rose 2.7% to US$28.75 over the past week.Reported Earnings • Apr 29First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: US$0.43 (up from US$0.41 in 1Q 2021). Revenue: US$37.5m (up 4.8% from 1Q 2021). Net income: US$10.6m (up 5.7% from 1Q 2021). Profit margin: 28% (in line with 1Q 2021). Revenue exceeded analyst estimates by 6.2%. Earnings per share (EPS) also surpassed analyst estimates by 34%. Over the next year, revenue is forecast to grow 106%, compared to a 11% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Reagan Reaud was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).Reported Earnings • Mar 01Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$151.3m (up 25% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 24% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Net interest margin (NIM): 3.31% (down from 3.73% in FY 2020). Cost-to-income ratio: 75.6% (up from 64.2% in FY 2020). Non-performing loans: 0.78% (down from 0.82% in FY 2020). Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 77%, compared to a 5.8% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Feb 03Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$253.4m to US$267.6m. EPS estimate increased from US$1.15 to US$1.32 per share. Net income forecast to grow 44% next year vs 7.1% decline forecast for Banks industry in the US. Consensus price target broadly unchanged at US$34.33. Share price fell 7.6% to US$28.53 over the past week.Reported Earnings • Jan 29Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$153.2m (up 26% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 23% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 65%, compared to a 4.3% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Dec 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 December 2021. Payment date: 14 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.3%).Price Target Changed • Nov 12Price target increased to US$32.00Up from US$29.33, the current price target is an average from 3 analysts. New target price is 7.6% above last closing price of US$29.73. Stock is up 35% over the past year. The company is forecast to post earnings per share of US$1.94 for next year compared to US$1.06 last year.Price Target Changed • Oct 30Price target decreased to US$29.33Down from US$31.67, the current price target is an average from 3 analysts. New target price is 7.8% above last closing price of US$27.20. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.06 last year.Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS US$0.59 (vs US$0.26 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$41.7m (up 47% from 3Q 2020). Net income: US$14.4m (up 125% from 3Q 2020). Profit margin: 35% (up from 23% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 6% per year.Upcoming Dividend • Sep 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 2.0%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.4%).Reported Earnings • Jul 31Second quarter 2021 earnings released: EPS US$0.48 (vs US$0.087 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$39.6m (up 57% from 2Q 2020). Net income: US$11.7m (up 441% from 2Q 2020). Profit margin: 30% (up from 8.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 11% per year.Upcoming Dividend • Jun 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 June 2021. Payment date: 15 July 2021. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (3.4%). Lower than average of industry peers (2.3%).분석 기사 • May 13Shareholders May Find It Hard To Justify A Pay Rise For CBTX, Inc.'s (NASDAQ:CBTX) CEO This YearThe share price of CBTX, Inc. ( NASDAQ:CBTX ) has struggled to grow by much over the last few years and probably has to...Major Estimate Revision • May 05Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from US$1.41 to US$1.66. Revenue forecast unchanged at US$143.0m. Net income forecast to grow 37% next year vs 7.1% growth forecast for Banks industry in the US. Consensus price target of US$32.33 unchanged from last update. Share price was steady at US$31.60 over the past week.Reported Earnings • May 03First quarter 2021 earnings released: EPS US$0.41 (vs US$0.30 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$35.8m (up 14% from 1Q 2020). Net income: US$10.0m (up 33% from 1Q 2020). Profit margin: 28% (up from 24% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Price Target Changed • Apr 10Price target increased to US$32.00Up from US$29.67, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$32.04. Stock is up 78% over the past year.Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).Reported Earnings • Mar 01Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has remained flat.Analyst Estimate Surprise Post Earnings • Mar 01Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 18% growth forecast for the Banks industry in the US.분석 기사 • Feb 25What Percentage Of CBTX, Inc. (NASDAQ:CBTX) Shares Do Insiders Own?A look at the shareholders of CBTX, Inc. ( NASDAQ:CBTX ) can tell us which group is most powerful. Institutions often...Is New 90 Day High Low • Feb 24New 90-day high: US$29.03The company is up 25% from its price of US$23.18 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$26.95 per share.Reported Earnings • Jan 30Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Net interest margin (NIM): 3.73% (down from 4.42% in FY 2019). Cost-to-income ratio: 64.2% (up from 58.3% in FY 2019). Non-performing loans: 0.82% (up from 0.04% in FY 2019). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 3% per year.Analyst Estimate Surprise Post Earnings • Jan 30Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 17% growth forecast for the Banks industry in the US.분석 기사 • Jan 30CBTX, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsCBTX, Inc. ( NASDAQ:CBTX ) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to...Is New 90 Day High Low • Jan 23New 90-day high: US$28.70The company is up 44% from its price of US$19.88 on 23 October 2020. The American market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 30% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.41 per share.분석 기사 • Jan 21Does CBTX, Inc. (NASDAQ:CBTX) Have A Place In Your Dividend Portfolio?Is CBTX, Inc. ( NASDAQ:CBTX ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...Is New 90 Day High Low • Jan 07New 90-day high: US$27.71The company is up 50% from its price of US$18.43 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.79 per share.Price Target Changed • Dec 29Price target raised to US$26.67Up from US$22.00, the current price target is an average from 3 analysts. The new target price is close to the current share price of US$26.26. As of last close, the stock is down 16% over the past year.분석 기사 • Dec 26There's A Lot To Like About CBTX's (NASDAQ:CBTX) Upcoming US$0.10 DividendIt looks like CBTX, Inc. ( NASDAQ:CBTX ) is about to go ex-dividend in the next 4 days. This means that investors who...Upcoming Dividend • Dec 24Upcoming Dividend of US$0.10 Per ShareWill be paid on the 15th of January to those who are registered shareholders by the 31st of December. The trailing yield of 1.5% is below the top quartile of American dividend payers (4.0%), and is lower than industry peers (2.9%).분석 기사 • Dec 23How Much Are CBTX, Inc. (NASDAQ:CBTX) Insiders Spending On Buying Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...Recent Insider Transactions Derivative • Dec 18Senior EVP exercised options to buy US$222k worth of stock.On the 15th of December, Robert Pigott exercised options to buy 8.83k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 16% of their direct individual holding at the time of the trade. Since March 2020, Robert has owned 55.95k shares directly. Company insiders have collectively bought US$2.9m more than they sold, via options and on-market transactions, in the last 12 months.Is New 90 Day High Low • Dec 16New 90-day high: US$24.62The company is up 51% from its price of US$16.34 on 16 September 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 23% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$27.77 per share.분석 기사 • Dec 02Our Take On CBTX's (NASDAQ:CBTX) CEO SalaryBob Franklin became the CEO of CBTX, Inc. ( NASDAQ:CBTX ) in 2013, and we think it's a good time to look at the...Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 19% share price gain to US$21.87, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 15.9x. This compares to an average P/E of 11x in the Banks industry in the US. Total return to shareholders over the past three years is a loss of 21%.Is New 90 Day High Low • Nov 04New 90-day high: US$19.90The company is up 21% from its price of US$16.45 on 06 August 2020. The American market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.31 per share.Analyst Estimate Surprise Post Earnings • Oct 30Third-quarter earnings released: Revenue and earnings beat expectationsThird-quarter revenue exceeded analyst estimates by 0.3% at US$35.7m. Earnings per share (EPS) also surpassed analyst estimates by 1.3% at US$0.26. Revenue is forecast to grow 15% over the next year, compared to a 18% growth forecast for the Banks industry in the US.Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total profits of US$28.8m, down 45% from the prior year. Total revenue was US$122.7m over the last 12 months, down 17% from the prior year.Is New 90 Day High Low • Oct 08New 90-day high: US$18.17The company is up 3.0% from its price of US$17.56 on 10 July 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$24.15 per share.Is New 90 Day High Low • Sep 22New 90-day low: US$15.00The company is down 23% from its price of US$19.36 on 24 June 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.70 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 배당금 지급이 안정적인 반면, CBTX 은(는) 배당금을 지급한 지 10년도 채 되지 않았습니다.배당금 증가: CBTX 의 배당금 지급이 증가했지만 회사는 5 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장CBTX 배당 수익률 vs 시장CBTX의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (CBTX)1.8%시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Banks)2.4%분석가 예측 (CBTX) (최대 3년)2.0%주목할만한 배당금: CBTX 의 배당금( 1.78% )은 US 시장에서 배당금 지급자의 하위 25%( 1.42% )보다 높습니다.고배당: CBTX 의 배당금( 1.78% )은 US 시장에서 배당금 지급자의 상위 25%( 4.25% )와 비교해 낮습니다.현재 주주 배당수익 보장: 합리적으로 낮은 지불 비율 ( 35.2% )로 CBTX 의 배당금 지급은 수익으로 충분히 충당됩니다.향후 주주 배당미래 배당 보장: 3년 안에 배당금이 지급될 것인지, 아니면 수익으로 충당될 것인지를 판단하기에는 데이터가 부족합니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/10/02 13:28종가2022/09/30 00:00수익2022/06/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스CBTX, Inc.는 3명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Christopher McGrattyKeefe, Bruyette, & WoodsBradley MilsapsPiper Sandler CompaniesMatthew OlneyStephens, Inc.
Upcoming Dividend • Jun 21Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 28 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (4.3%). Lower than average of industry peers (3.2%).
Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).
Upcoming Dividend • Dec 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 December 2021. Payment date: 14 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.3%).
Upcoming Dividend • Sep 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 2.0%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.4%).
Upcoming Dividend • Jun 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 June 2021. Payment date: 15 July 2021. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (3.4%). Lower than average of industry peers (2.3%).
Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).
Recent Insider Transactions Derivative • Sep 27Senior EVP & CCO exercised options to buy US$192k worth of stock.On the 23rd of September, Joe West exercised options to buy 6k shares at a strike price of around US$11.32, costing a total of US$73k. This transaction amounted to 11% of their direct individual holding at the time of the trade. Since March 2022, Joe's direct individual holding has increased from 49.01k shares to 57.84k. Company insiders have collectively bought US$237k more than they sold, via options and on-market transactions, in the last 12 months.
Seeking Alpha • Sep 22CBTX declares $0.13 dividendCBTX (NASDAQ:CBTX) declares $0.13/share quarterly dividend, in line with previous. Forward yield 1.67% Payable Oct. 14; for shareholders of record Sept. 29; ex-div Sept. 28. See CBTX Dividend Scorecard, Yield Chart, & Dividend Growth.
Buying Opportunity • Sep 21Now 20% undervaluedOver the last 90 days, the stock is up 15%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.
Buying Opportunity • Aug 25Now 20% undervaluedOver the last 90 days, the stock is up 9.5%. The fair value is estimated to be US$38.96, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 12%. Revenue is forecast to grow by 128% in a year. Earnings is forecast to grow by 223% in the next year.
Major Estimate Revision • Aug 04Consensus revenue estimates fall by 15%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from US$297.8m to US$254.6m. EPS estimate fell from US$1.73 to US$1.54 per share. Net income forecast to grow 200% next year vs 9.8% growth forecast for Banks industry in the US. Consensus price target up from US$32.67 to US$34.67. Share price was steady at US$30.66 over the past week.
Reported Earnings • Jul 29Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: US$0.48 (up from US$0.48 in 2Q 2021). Revenue: US$38.3m (down 3.3% from 2Q 2021). Net income: US$11.7m (flat on 2Q 2021). Profit margin: 31% (up from 30% in 2Q 2021). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) exceeded analyst estimates by 13%. Over the next year, revenue is forecast to grow 147%, compared to a 15% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
Seeking Alpha • Jul 28CBTX GAAP EPS of $0.48 beats by $0.06, revenue of $38.42M misses by $1.13MCBTX press release (NASDAQ:CBTX): Q2 GAAP EPS of $0.48 beats by $0.06. Revenue of $38.42M (+11.3% Y/Y) misses by $1.13M.
Upcoming Dividend • Jun 21Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 28 June 2022. Payment date: 15 July 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (4.3%). Lower than average of industry peers (3.2%).
Recent Insider Transactions • Jun 09Independent Director recently bought US$300k worth of stockOn the 3rd of June, Michael Havard bought around 10k shares on-market at roughly US$28.60 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought US$64k more in shares than they have sold in the last 12 months.
Recent Insider Transactions Derivative • Jun 08Senior EVP & CCO exercised options to buy US$253k worth of stock.On the 4th of June, Joe West exercised options to buy 9k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 18% of their direct individual holding at the time of the trade. Since March 2022, Joe has owned 49.01k shares directly. Company insiders have collectively sold US$135k more than they bought, via options and on-market transactions in the last 12 months.
Recent Insider Transactions • May 07Insider recently sold US$235k worth of stockOn the 5th of May, Deborah Dinsmore sold around 8k shares on-market at roughly US$28.70 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Major Estimate Revision • May 05Consensus EPS estimates increase by 12%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$276.8m to US$285.2m. EPS estimate increased from US$1.47 to US$1.65 per share. Net income forecast to grow 135% next year vs 2.6% growth forecast for Banks industry in the US. Consensus price target of US$33.67 unchanged from last update. Share price rose 2.7% to US$28.75 over the past week.
Reported Earnings • Apr 29First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: US$0.43 (up from US$0.41 in 1Q 2021). Revenue: US$37.5m (up 4.8% from 1Q 2021). Net income: US$10.6m (up 5.7% from 1Q 2021). Profit margin: 28% (in line with 1Q 2021). Revenue exceeded analyst estimates by 6.2%. Earnings per share (EPS) also surpassed analyst estimates by 34%. Over the next year, revenue is forecast to grow 106%, compared to a 11% growth forecast for the industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Independent Director Reagan Reaud was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 15 April 2022. Payout ratio is a comfortable 36% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).
Reported Earnings • Mar 01Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$151.3m (up 25% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 24% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Net interest margin (NIM): 3.31% (down from 3.73% in FY 2020). Cost-to-income ratio: 75.6% (up from 64.2% in FY 2020). Non-performing loans: 0.78% (down from 0.82% in FY 2020). Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 77%, compared to a 5.8% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Feb 03Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in 2022 has improved. 2022 revenue forecast increased from US$253.4m to US$267.6m. EPS estimate increased from US$1.15 to US$1.32 per share. Net income forecast to grow 44% next year vs 7.1% decline forecast for Banks industry in the US. Consensus price target broadly unchanged at US$34.33. Share price fell 7.6% to US$28.53 over the past week.
Reported Earnings • Jan 29Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: US$1.46 (up from US$1.07 in FY 2020). Revenue: US$153.2m (up 26% from FY 2020). Net income: US$35.6m (up 35% from FY 2020). Profit margin: 23% (up from 22% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 15%. Over the next year, revenue is forecast to grow 65%, compared to a 4.3% growth forecast for the banks industry in the US. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Dec 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 December 2021. Payment date: 14 January 2022. Payout ratio is a comfortable 26% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.3%).
Price Target Changed • Nov 12Price target increased to US$32.00Up from US$29.33, the current price target is an average from 3 analysts. New target price is 7.6% above last closing price of US$29.73. Stock is up 35% over the past year. The company is forecast to post earnings per share of US$1.94 for next year compared to US$1.06 last year.
Price Target Changed • Oct 30Price target decreased to US$29.33Down from US$31.67, the current price target is an average from 3 analysts. New target price is 7.8% above last closing price of US$27.20. Stock is up 44% over the past year. The company is forecast to post earnings per share of US$1.72 for next year compared to US$1.06 last year.
Reported Earnings • Oct 30Third quarter 2021 earnings released: EPS US$0.59 (vs US$0.26 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: US$41.7m (up 47% from 3Q 2020). Net income: US$14.4m (up 125% from 3Q 2020). Profit margin: 35% (up from 23% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 6% per year.
Upcoming Dividend • Sep 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 September 2021. Payment date: 15 October 2021. Trailing yield: 2.0%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.4%).
Reported Earnings • Jul 31Second quarter 2021 earnings released: EPS US$0.48 (vs US$0.087 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: US$39.6m (up 57% from 2Q 2020). Net income: US$11.7m (up 441% from 2Q 2020). Profit margin: 30% (up from 8.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 11% per year.
Upcoming Dividend • Jun 23Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 30 June 2021. Payment date: 15 July 2021. Trailing yield: 1.9%. Lower than top quartile of American dividend payers (3.4%). Lower than average of industry peers (2.3%).
분석 기사 • May 13Shareholders May Find It Hard To Justify A Pay Rise For CBTX, Inc.'s (NASDAQ:CBTX) CEO This YearThe share price of CBTX, Inc. ( NASDAQ:CBTX ) has struggled to grow by much over the last few years and probably has to...
Major Estimate Revision • May 05Consensus forecasts updatedThe consensus outlook for 2021 has been updated. 2021 EPS estimate increased from US$1.41 to US$1.66. Revenue forecast unchanged at US$143.0m. Net income forecast to grow 37% next year vs 7.1% growth forecast for Banks industry in the US. Consensus price target of US$32.33 unchanged from last update. Share price was steady at US$31.60 over the past week.
Reported Earnings • May 03First quarter 2021 earnings released: EPS US$0.41 (vs US$0.30 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$35.8m (up 14% from 1Q 2020). Net income: US$10.0m (up 33% from 1Q 2020). Profit margin: 28% (up from 24% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Price Target Changed • Apr 10Price target increased to US$32.00Up from US$29.67, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$32.04. Stock is up 78% over the past year.
Upcoming Dividend • Mar 24Upcoming dividend of US$0.13 per shareEligible shareholders must have bought the stock before 31 March 2021. Payment date: 15 April 2021. Trailing yield: 1.8%. Lower than top quartile of American dividend payers (3.6%). Lower than average of industry peers (2.4%).
Reported Earnings • Mar 01Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has remained flat.
Analyst Estimate Surprise Post Earnings • Mar 01Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 18% growth forecast for the Banks industry in the US.
분석 기사 • Feb 25What Percentage Of CBTX, Inc. (NASDAQ:CBTX) Shares Do Insiders Own?A look at the shareholders of CBTX, Inc. ( NASDAQ:CBTX ) can tell us which group is most powerful. Institutions often...
Is New 90 Day High Low • Feb 24New 90-day high: US$29.03The company is up 25% from its price of US$23.18 on 25 November 2020. The American market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$26.95 per share.
Reported Earnings • Jan 30Full year 2020 earnings released: EPS US$1.07 (vs US$2.03 in FY 2019)The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: US$123.7m (down 15% from FY 2019). Net income: US$26.4m (down 48% from FY 2019). Profit margin: 21% (down from 35% in FY 2019). The decrease in margin was primarily driven by lower revenue. Net interest margin (NIM): 3.73% (down from 4.42% in FY 2019). Cost-to-income ratio: 64.2% (up from 58.3% in FY 2019). Non-performing loans: 0.82% (up from 0.04% in FY 2019). Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 3% per year.
Analyst Estimate Surprise Post Earnings • Jan 30Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 0.4%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Over the next year, revenue is forecast to grow 13%, compared to a 17% growth forecast for the Banks industry in the US.
분석 기사 • Jan 30CBTX, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsCBTX, Inc. ( NASDAQ:CBTX ) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to...
Is New 90 Day High Low • Jan 23New 90-day high: US$28.70The company is up 44% from its price of US$19.88 on 23 October 2020. The American market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 30% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.41 per share.
분석 기사 • Jan 21Does CBTX, Inc. (NASDAQ:CBTX) Have A Place In Your Dividend Portfolio?Is CBTX, Inc. ( NASDAQ:CBTX ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
Is New 90 Day High Low • Jan 07New 90-day high: US$27.71The company is up 50% from its price of US$18.43 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$28.79 per share.
Price Target Changed • Dec 29Price target raised to US$26.67Up from US$22.00, the current price target is an average from 3 analysts. The new target price is close to the current share price of US$26.26. As of last close, the stock is down 16% over the past year.
분석 기사 • Dec 26There's A Lot To Like About CBTX's (NASDAQ:CBTX) Upcoming US$0.10 DividendIt looks like CBTX, Inc. ( NASDAQ:CBTX ) is about to go ex-dividend in the next 4 days. This means that investors who...
Upcoming Dividend • Dec 24Upcoming Dividend of US$0.10 Per ShareWill be paid on the 15th of January to those who are registered shareholders by the 31st of December. The trailing yield of 1.5% is below the top quartile of American dividend payers (4.0%), and is lower than industry peers (2.9%).
분석 기사 • Dec 23How Much Are CBTX, Inc. (NASDAQ:CBTX) Insiders Spending On Buying Shares?We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Recent Insider Transactions Derivative • Dec 18Senior EVP exercised options to buy US$222k worth of stock.On the 15th of December, Robert Pigott exercised options to buy 8.83k shares at a strike price of around US$11.32, costing a total of US$100k. This transaction amounted to 16% of their direct individual holding at the time of the trade. Since March 2020, Robert has owned 55.95k shares directly. Company insiders have collectively bought US$2.9m more than they sold, via options and on-market transactions, in the last 12 months.
Is New 90 Day High Low • Dec 16New 90-day high: US$24.62The company is up 51% from its price of US$16.34 on 16 September 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 23% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$27.77 per share.
분석 기사 • Dec 02Our Take On CBTX's (NASDAQ:CBTX) CEO SalaryBob Franklin became the CEO of CBTX, Inc. ( NASDAQ:CBTX ) in 2013, and we think it's a good time to look at the...
Valuation Update With 7 Day Price Move • Nov 11Market bids up stock over the past weekAfter last week's 19% share price gain to US$21.87, the stock is trading at a trailing P/E ratio of 18.9x, up from the previous P/E ratio of 15.9x. This compares to an average P/E of 11x in the Banks industry in the US. Total return to shareholders over the past three years is a loss of 21%.
Is New 90 Day High Low • Nov 04New 90-day high: US$19.90The company is up 21% from its price of US$16.45 on 06 August 2020. The American market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Banks industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.31 per share.
Analyst Estimate Surprise Post Earnings • Oct 30Third-quarter earnings released: Revenue and earnings beat expectationsThird-quarter revenue exceeded analyst estimates by 0.3% at US$35.7m. Earnings per share (EPS) also surpassed analyst estimates by 1.3% at US$0.26. Revenue is forecast to grow 15% over the next year, compared to a 18% growth forecast for the Banks industry in the US.
Reported Earnings • Oct 30Third quarter earnings releasedOver the last 12 months the company has reported total profits of US$28.8m, down 45% from the prior year. Total revenue was US$122.7m over the last 12 months, down 17% from the prior year.
Is New 90 Day High Low • Oct 08New 90-day high: US$18.17The company is up 3.0% from its price of US$17.56 on 10 July 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$24.15 per share.
Is New 90 Day High Low • Sep 22New 90-day low: US$15.00The company is down 23% from its price of US$19.36 on 24 June 2020. The American market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Banks industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is US$23.70 per share.